MARGARET SECKAR: Open Payments
NPI 1578849824 · OAKHURST, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,298 in 210 payments from 20 companies in 2025. Trend: 2023 $1,616 · 2024 $2,123 · 2025 $3,298
Food & beverage: $3,073Consulting: $215Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 44 | $677 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 23 | $425 |
| Janssen Biotech, Inc. | 22 | $356 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $319 |
| Madrigal Pharmaceuticals | 23 | $262 |
| Johnson & Johnson Health Care Systems Inc. | 1 | $215 |
| PFIZER INC. | 11 | $206 |
| Ardelyx, Inc. | 9 | $148 |
| Aimmune Therapeutics, Inc. | 29 | $142 |
| Ipsen Biopharmaceuticals, Inc | 5 | $95 |
Products named: TREMFYA, RINVOQ, XIFAXAN, REZDIFFRA, ENTYVIO, IBSRELA, ZENPEP, VELSIPITY.
Industry payments across NJ — which companies pay providers there.
